NURESCA owner Contact Information online
from Pfizer Inc.
NURESCA
US serial number:85182627
Application filling date:Nov. 22, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jan. 19, 2015
Publication date:Oct. 18, 2011
Abandoned date:Jan. 19, 2015
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of infectious diseases, and immunological and viral disorders
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations for the treatment of infectious diseases
and immunological and viral disorders
Current owner owner name:Pfizer Inc.
Current owner owner address:235 East 42nd Street
New York,
NEW YORK
UNITED STATES
10017
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Matthew A. Pater
Attorney email:deadlinesipnyo@pfizer.com
Attorney email authorized:Yes
Correspondent name address:MATTHEW A. PATER
PFIZER INC.
150 E 42ND ST
NEW YORK,
NEW YORK
UNITED STATES
10017-5612
Correspondent phone:212-733-9778
Correspondent email:deadlinesipnyo@pfizer.com
Correspondent fax:212-573-2273
Correspondent email authorized:Yes
Trademark staff tm attorney:PARKER, JUSTINE D
Trademark staff law office assigned NURESCA:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Bayer Aktiengesellschaft (48) Pfizer Inc. (47) Windmill Health Products, LLC (46) SANOFI (41) Wyeth LLC (41) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Oct. 18, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010
